{"drugs":["Thiethylperazine Maleate","Torecan"],"mono":{"0":{"id":"626088-s-0","title":"Generic Names","mono":"Thiethylperazine Maleate"},"1":{"id":"626088-s-1","title":"Dosing and Indications","sub":{"0":{"id":"626088-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Nausea and vomiting:<\/b> 10 mg IM, ORALLY, OR RECTALLY 1-3 times a day<\/li><li><b>Nausea and vomiting:<\/b> postoperative, 10 mg IM at or shortly before the termination of anesthesia<\/li><\/ul>"},"1":{"id":"626088-s-1-5","title":"Pediatric Dosing","mono":"Safety and efficacy have not been established in children"},"3":{"id":"626088-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Nausea and vomiting<br\/>"}}},"3":{"id":"626088-s-3","title":"Contraindications\/Warnings","sub":[{"id":"626088-s-3-9","title":"Contraindications","mono":"<ul><li>children and adolescents with symptoms and signs suggestive of Reye's syndrome<\/li><li>hypersensitivity to thiethylperazine or to other phenothiazines<\/li><li>marked hypotension<\/li><li>severe central nervous system depression and comatose states<\/li><\/ul>"},{"id":"626088-s-3-10","title":"Precautions","mono":"<ul><li>can potentiate the effects or actions of other CNS depressants such as alcohol, opiates, anesthetics, barbiturates, and tranquilizers<\/li><li>drowsiness can be hazardous in individuals requiring alertness<\/li><li>injection contains sodium metabisulfite which may cause allergic reactions, including anaphylactic symptoms and life-threatening asthmatic episodes, in susceptible individuals<\/li><li>may accentuate the fall in blood pressure when given to patients who have received spinal or epidural anesthesia, or adrenergic blocking agents<\/li><li>may mask symptoms of organic disease, such as GI or CNS disorders, as well as the toxic effects of other drugs<\/li><li>moderate hypotension has been occasionally observed within 30 minutes following administration of the drug in patients recovering from anesthesia<\/li><li>patients with a history of dyskinetic reactions<\/li><li>patients with moderate to severe hepatic dysfunction<\/li><li>pregnant women with preeclampsia, as these patients may have labile blood pressures and may experience a significant fall in blood pressure with the drug<\/li><li>restlessness and postoperative CNS depression during recovery from anesthesia have been observed<\/li><li>tablets contain tartrazine which may cause allergic reactions, including bronchial asthma, in susceptible individuals<\/li><\/ul>"},{"id":"626088-s-3-11","title":"Pregnancy Category","mono":"Thiethylperazine: C (AUS)<br\/>"},{"id":"626088-s-3-12","title":"Breast Feeding","mono":"Thiethylperazine: Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"4":{"id":"626088-s-4","title":"Drug Interactions","sub":{"1":{"id":"626088-s-4-14","title":"Major","mono":"<ul><li>Donepezil (theoretical)<\/li><li>Fentanyl (theoretical)<\/li><li>Gatifloxacin (probable)<\/li><li>Hydrocodone (theoretical)<\/li><li>Ibutilide (theoretical)<\/li><li>Isradipine (theoretical)<\/li><li>Levorphanol (theoretical)<\/li><li>Methadone (theoretical)<\/li><li>Metrizamide (theoretical)<\/li><li>Morphine (theoretical)<\/li><li>Morphine Sulfate Liposome (theoretical)<\/li><li>Octreotide (theoretical)<\/li><li>Oxymorphone (theoretical)<\/li><li>Pentamidine (theoretical)<\/li><li>Procarbazine (probable)<\/li><li>Suvorexant (theoretical)<\/li><li>Tapentadol (theoretical)<\/li><li>Tramadol (theoretical)<\/li><\/ul>"},"2":{"id":"626088-s-4-15","title":"Moderate","mono":"<ul><li>Belladonna (probable)<\/li><li>Belladonna Alkaloids (probable)<\/li><li>Betel Nut (probable)<\/li><li>Evening Primrose (probable)<\/li><li>Meperidine (probable)<\/li><li>Phenylalanine (probable)<\/li><\/ul>"}}},"5":{"id":"626088-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Neurologic:<\/b>Dizziness, Somnolence<br\/><b>Serious<\/b><ul><li><b>Cardiovascular:<\/b>Hypotension<\/li><li><b>Hematologic:<\/b>Agranulocytosis (rare), Leukopenia (rare), Pancytopenia (rare), Thrombocytopenia (rare)<\/li><li><b>Hepatic:<\/b>Cholestatic jaundice syndrome (rare)<\/li><li><b>Neurologic:<\/b>Seizure (rare)<\/li><\/ul>"},"6":{"id":"626088-s-6","title":"Drug Name Info","sub":{"0":{"id":"626088-s-6-17","title":"US Trade Names","mono":"Torecan<br\/>"},"2":{"id":"626088-s-6-19","title":"Class","mono":"<ul><li>Antiemetic<\/li><li>Phenothiazine<\/li><li>Piperazine (class)<\/li><\/ul>"},"3":{"id":"626088-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"626088-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"9":{"id":"626088-s-9","title":"Administration","mono":"<b>General Information<\/b><br\/>IM use only; do not administer IV<br\/>"},"11":{"id":"626088-s-11","title":"How Supplied","mono":"<b>Torecan<\/b><br\/>Oral Tablet: 10 MG<br\/>"},"13":{"id":"626088-s-13","title":"Clinical Teaching","mono":"<ul><li>Tell patient to avoid activities requiring mental alertness until drug effects are realized, as drug may cause somnolence.<\/li><li>Instruct patient to rise slowly from a sitting\/supine position to decrease occurrence of dizziness or symptomatic hypotension.<\/li><li>Patient should not drink alcohol while taking this drug.<\/li><\/ul>"}}}